North America
Deals of The Day — Mergers and Acquisitions
The following bids, mergers, acquisitions and disposals were reported on Wednesday. The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday: Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.
Biogen's Purchase of Multiple Sclerosis Drug Ends Rocky Partnership with Elan
Biogen Idec agreement to buy Elan Corp's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious.
SEC puts Private Equity in its Sights
Securities and Exchange Commission said late last month that the agency has its eye on several private-equity industry practices
Nexstar Broadcasting Announces Secondary Stock Offering
Nexstar Broadcasting Group announces secondary offering of common stock by selling stockholders Nexstar Broadcasting Group, Inc. (NASDAQ: NXST) today announced that selling stockholders, funds affiliated with ABRY Partners, LLC, intend to offer 3.




